MUMBAI Feb 14 India's largest drugmaker Sun
Pharmaceutical Industries Ltd's third-quarter profit
fell below analysts' estimates due to slower sales in the United
States, its largest market.
Sun's net profit for the October-December period fell to
14.72 billion rupees ($219.87 million) from 15.45 billion rupees
a year earlier. Analysts on average expected a profit of 17.83
billion rupees, according to Thomson Reuters I/B/E/S.
Sun said quarterly U.S. sales rose 4 percent over the year
earlier. The company's U.S. subsidiary Taro Pharmaceutical
Industries Ltd last week reported third-quarter sales
down 15 percent over the last year.
($1 = 66.9500 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Himani Sarkar
and Vyas Mohan)